Insights on increasing the translational value of your preclinical development program.
Dec 11, 2023by MD Biosciences
The goal of preclinical drug development is to identify potential therapeutic compounds and gain an understanding of...
Oct 18, 2023by MD Biosciences
Neuroma in humans is a challenging condition that often leads to persistent pain in residual limbs. Despite its...
Sep 25, 2023by MD Biosciences
MD Biosciences has published a new article in the Journal of Pain describing a novel sensory wave (P25) in the ...
Jan 10, 2023by MD Biosciences
As the general population continues to age, the economic burden of chronic pain and neurodegenerative diseases is...
Sep 20, 2022by MD Biosciences
An excerpt from MD Biosciences publication in the Autumn 2022 issue of Göttingen Minipigs Magazine.
MD Biosciences...
.png?width=800&name=POP%20in%20pigs%20webinar%20(1).png)
